FYR Diagnostics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $8M

  • Investors
  • 6

FYR Diagnostics General Information

Description

Developer of a multi-omic profiling platform designed to decode RNA and protein signals in blood. The company's platform utilizes artificial intelligence and proprietary extracellular vesicle enrichment technology to analyze cellular proteins and nucleic acids from peripheral blood samples, enabling biopharma and clinical partners to discover biomarkers, design smarter trials, and monitor treatment response dynamically.

Contact Information

Website
www.fyr.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1121 East Broadway Street
  • Missoula, MT 59802
  • United States
+1 (406)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 1121 East Broadway Street
  • Missoula, MT 59802
  • United States
+1 (406)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FYR Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 24-Sep-2025 $8M Completed Generating Revenue
4. Grant 15-Aug-2021 Completed Product Development
3. Grant 10-Oct-2019 Completed Product Development
2. Seed Round 01-Jan-2019 $650K $650K Completed Product Development
1. Accelerator/Incubator Completed Product Development
To view FYR Diagnostics’s complete valuation and funding history, request access »

FYR Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2C
Seed-2B
Seed-2A 11,210,063 $0.000010 5% $0.85 $0.85 1x $0.85 18.59%
Seed 1,250,000 $0.000010 5% $0.52 $0.52 1x $0.52 5.6%
To view FYR Diagnostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

FYR Diagnostics Patents

FYR Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026178346-A1 Bias reduction for machine learning feature selection Pending 21-Feb-2025
WO-2026050159-A1 Compositions and methods for detection of gene expression Pending 26-Aug-2024

FYR Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FYR Diagnostics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Sontag Foundation Limited Partner Minority
Yuvaan Tiwari Foundation Not-For-Profit Venture Capital Minority
National Institutes of Health Government
National Institutes of Neurological Disorders and Stroke Government
Two Bear Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

FYR Diagnostics FAQs

  • When was FYR Diagnostics founded?

    FYR Diagnostics was founded in 2016.

  • Where is FYR Diagnostics headquartered?

    FYR Diagnostics is headquartered in Missoula, MT.

  • What is the size of FYR Diagnostics?

    FYR Diagnostics has 18 total employees.

  • What industry is FYR Diagnostics in?

    FYR Diagnostics’s primary industry is Discovery Tools (Healthcare).

  • Is FYR Diagnostics a private or public company?

    FYR Diagnostics is a Private company.

  • What is the current valuation of FYR Diagnostics?

    The current valuation of FYR Diagnostics is .

  • What is FYR Diagnostics’s current revenue?

    The current revenue for FYR Diagnostics is .

  • How much funding has FYR Diagnostics raised over time?

    FYR Diagnostics has raised $8.65M.

  • Who are FYR Diagnostics’s investors?

    The Sontag Foundation, Yuvaan Tiwari Foundation, National Institutes of Health, National Institutes of Neurological Disorders and Stroke, and Two Bear Capital are 5 of 6 investors who have invested in FYR Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process